Breaking the Gut-Liver Axis: Breakthrough Experimental Drug Reverses Severe Fatty Liver Disease
In a significant advancement for hepatology and metabolic medicine, researchers at Michigan Medicine have unveiled a promising new therapeutic strategy to combat metabolic dysfunction-associated steatohepatitis (MASH). A study published in The Journal of…
Breaking the Barrier: Researchers Uncover Potential Breakthrough in Treating Aggressive Liver Cancer
In the landscape of oncology, few diagnoses are as daunting as fibrolamellar carcinoma (FLC). A rare, aggressive form of liver cancer that predominantly strikes children and young adults, FLC has long been a clinical enigma. It is a disease defined by…